The Procedures for the Review of Breakthrough Therapy Drugs (Trial) was issued on Jul.08, 2020. It aims to promote the implementation of the Drug Registration Administration Measures, which includes relevant policies, regulations, and measures.
- Local Title:突破性治疗药物审评工作程序（试行）
- Country/Region:Chinese Mainland
- Competent Authority: National Medical Products Administration (NMPA)
- Type:Regulation
- Status:In force
- Release Date:2020-07-08
- Implementation Date:2020-07-08